These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 8826947

  • 1. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
    Nikaido T, Li SF, Shiozawa T, Fujii S.
    Cancer; 1996 Sep 15; 78(6):1248-53. PubMed ID: 8826947
    [Abstract] [Full Text] [Related]

  • 2. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma.
    Li SF, Shiozawa T, Nakayama K, Nikaido T, Fujii S.
    Cancer; 1996 Jan 15; 77(2):321-9. PubMed ID: 8625241
    [Abstract] [Full Text] [Related]

  • 3. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
    Horrée N, van Diest PJ, van der Groep P, Sie-Go DM, Heintz AP.
    J Clin Pathol; 2008 Jan 15; 61(1):36-42. PubMed ID: 17483252
    [Abstract] [Full Text] [Related]

  • 4. Cyclin D1 gene expression in human cervical neoplasia.
    Nichols GE, Williams ME, Gaffey MJ, Stoler MH.
    Mod Pathol; 1996 Apr 15; 9(4):418-25. PubMed ID: 8729983
    [Abstract] [Full Text] [Related]

  • 5. p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas.
    Gimenez-Conti IB, Collet AM, Lanfranchi H, Itoiz ME, Luna M, Xu HJ, Hu SX, Benedict WF, Conti CJ.
    Cancer; 1996 Jul 01; 78(1):17-23. PubMed ID: 8646714
    [Abstract] [Full Text] [Related]

  • 6. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.
    Br J Cancer; 2001 Jan 01; 84(2):270-5. PubMed ID: 11161387
    [Abstract] [Full Text] [Related]

  • 7. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
    Nishimura Y, Watanabe J, Jobo T, Kato N, Fujisawa T, Kamata Y, Kuramoto H.
    Anticancer Res; 2004 Jan 01; 24(4):2185-91. PubMed ID: 15330159
    [Abstract] [Full Text] [Related]

  • 8. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A.
    Mod Pathol; 1995 Jun 01; 8(5):560-7. PubMed ID: 7675778
    [Abstract] [Full Text] [Related]

  • 9. Expression of cyclin D1 in endometrial hyperplasia and endometrial carcinoma.
    Choudhury M, Bansal S.
    Indian J Pathol Microbiol; 2007 Oct 01; 50(4):708-10. PubMed ID: 18306533
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A, Ioachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S, Agnantis NJ.
    In Vivo; 2003 Oct 01; 17(5):469-77. PubMed ID: 14598611
    [Abstract] [Full Text] [Related]

  • 11. p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium.
    Horn LC, Richter CE, Einenkel J, Tannapfel A, Liebert UG, Leo C.
    Ann Diagn Pathol; 2006 Aug 01; 10(4):193-6. PubMed ID: 16844559
    [Abstract] [Full Text] [Related]

  • 12. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
    Burke L, Flieder DB, Guinee DG, Brambilla E, Freedman AN, Bennett WP, Jones RT, Borkowski A, Caporaso NA, Fleming M, Trastek V, Pairolero P, Tazelaar H, Midthun D, Jett JR, Liotta LA, Travis WD, Harris CC.
    Clin Cancer Res; 2005 Jan 01; 11(1):232-41. PubMed ID: 15671551
    [Abstract] [Full Text] [Related]

  • 13. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G, Antonaci A, Bosco D, Nardoni S, Melis M.
    J Exp Clin Cancer Res; 1999 Sep 01; 18(3):363-7. PubMed ID: 10606183
    [Abstract] [Full Text] [Related]

  • 14. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T, Massi D, Paglierani M, Masciullo V, Scambia G, Giordano A, Amunni G, Massi G, Taddei GL.
    Hum Pathol; 2001 Apr 01; 32(4):360-7. PubMed ID: 11331952
    [Abstract] [Full Text] [Related]

  • 15. A comparative analysis of Ki-67, p53, and p21WAF1CIP1 expression in tamoxifen associated endometrial carcinomas.
    Ramondetta LM, Palazzo JP, Dunton CJ, Kovatich AJ, Carlson JA.
    Anticancer Res; 1998 Apr 01; 18(6B):4661-5. PubMed ID: 9891537
    [Abstract] [Full Text] [Related]

  • 16. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ.
    J Exp Clin Cancer Res; 2004 Jun 01; 23(2):277-83. PubMed ID: 15354413
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
    Vaskivuo TE, Stenbäck F, Tapanainen JS.
    Cancer; 2002 Oct 01; 95(7):1463-71. PubMed ID: 12237915
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB.
    Oncogene; 1993 Dec 01; 8(12):3447-57. PubMed ID: 8247550
    [Abstract] [Full Text] [Related]

  • 19. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
    Burnworth B, Arendt S, Muffler S, Steinkraus V, Bröcker EB, Birek C, Hartschuh W, Jauch A, Boukamp P.
    Eur J Cell Biol; 2007 Dec 01; 86(11-12):763-80. PubMed ID: 17198740
    [Abstract] [Full Text] [Related]

  • 20. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS, Lee HS, Jung EJ, Kim CW, Lee BL, Kim WH.
    Int J Oncol; 2005 Nov 01; 27(5):1265-72. PubMed ID: 16211221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.